Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms
Authors:
- Lucas BleicherLBLucas Bleicher
- Ricardo AparicioRARicardo Aparicio
- Fabio M NunesFNFabio M Nunes
- Leandro MartinezLMLeandro Martinez
- Sandra M Gomes DiasSDSandra M Gomes Dias
- Ana Carolina Migliorini FigueiraAFAna Carolina Migliorini Figueira
- Maria Auxiliadora Morim SantosMSMaria Auxiliadora Morim Santos
- Rosangela da SilvaRSRosangela da Silva
- Paulo Marcos DonatePDPaulo Marcos Donate
- Francisco Ar NevesFNFrancisco Ar Neves
- Luiz A SimeoniLSLuiz A Simeoni
Open Access
- 31 January 2008
- journal article
- Published by Springer Nature in BMC Structural Biology
- Vol. 8 (1) , 8
Abstract
Background: Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor©) in studies in rats, mice and monkeys. Results: To investigate GC-1 specificity, we solved crystal structures and performed molecular dynamics simulations of both isoforms complexed with GC-1. Crystal structures reveal that, in TRα Arg228 is observed in multiple conformations, an effect triggered by the differences in the interactions between GC-1 and Ser277 or the corresponding asparagine (Asn331) of TRβ. The corresponding Arg282 of TRβ is observed in only one single stable conformation, interacting effectively with the ligand. Molecular dynamics support this model: our simulations show that the multiple conformations can be observed for the Arg228 in TRα, in which the ligand interacts either strongly with the ligand or with the Ser277 residue. In contrast, a single stable Arg282 conformation is observed for TRβ, in which it strongly interacts with both GC-1 and the Asn331. Conclusion: Our analysis suggests that the key factors for GC-1 selectivity are the presence of an oxyacetic acid ester oxygen and the absence of the amino group relative to T3. These results shed light into the β-selectivity of GC-1 and may assist the development of new compounds with potential as drug candidates to the treatment of hypercholesterolemia and obesity.Keywords
This publication has 48 references indexed in Scilit:
- Structural Rearrangements in the Thyroid Hormone Receptor Hinge Domain and Their Putative Role in the Receptor FunctionJournal of Molecular Biology, 2006
- Molecular Dynamics Simulations of Ligand Dissociation from Thyroid Hormone Receptors: Evidence of the Likeliest Escape Pathway and Its Implications for the Design of Novel LigandsJournal of Medicinal Chemistry, 2005
- The Thyroid Hormone Receptor β-Specific Agonist GC-1 Selectively Affects the Bone Development of Hypothyroid RatsJournal of Bone and Mineral Research, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weightTrends in Endocrinology & Metabolism, 2004
- Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimeticsBioorganic & Medicinal Chemistry Letters, 2003
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- [20] Processing of X-ray diffraction data collected in oscillation mode1997
- Editorial: thyroid hormone action and cardiac contractility - a complex affairEndocrinology, 1996
- THE EFFECT OF CERTAIN THYROXINE ANALOGUES ON THE SERUM LIPIDS IN HUMAN SUBJECTSJournal of Endocrinology, 1960